1. P496 Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study. (27th May 2021) Authors: Smith, P J; Storey, D; Gregg, B; Critchley, L; Stenson, J; Kneebone, A; Rimmer, T; Burke, S; Hussain, S; Teoh, W Y; Vazeille, S; Serna, S; Bond, A; Steel, A; Dibb, M; Collins, P; Derbyshire, E; Bodger, K; Probert, C; Verma, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PSVIII-27 Flunixin meglumine does not inhibit hyperthermia induced by central administration of α-1-acid-glycoprotein, an acute phase protein, in sheep. (7th December 2018) Authors: Daniel, J; Gregg, B; Parker, P; Waller, K; Garcia, M; Bradford, B Journal: Journal of animal science Issue: Volume 96(2018)Supplement 3 Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTH-049 Successful Reversal of High Titre Antibodies to Infliximab and Adalimumab with The Addition of Immunomodulator Therapy. (17th August 2016) Authors: Bond, A; Clark, K; Gregg, B; Collins, P; Dibb, M; Probert, C; Subramanian, S Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PWE-062 Effectiveness and safety of vedolizumab (vdz) in ibd patients: a multicentre experience of 'real world data' from the uk. (17th June 2017) Authors: Lenti, MV; Levison, S; Eliadou, E; Willert, R Robert; Kemp, K; Stansfield, C; Assadsangabi, A; Singh, S; Crooks, B; Tattersall, S; Kenneth, C; Subramanian, S; Probert, C; Storey, D; Gregg, B; Smith, P; Liu, E; Limdi, JK; Johnston, A; Hamlin, PJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PWE-078 Mean Corpuscular Volume But Not Lymphocyte Count Is A Predictor Of Thiopurine Dose Adequacy And Toxicity. (9th June 2014) Authors: Kneebone, A; Poon, SS; Asher, R; Jackson, R; Gregg, B; Kerr, S; Collins, P; Probert, C; Subramanian, S; Dibb, M Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PWE-100 Increasing Weight And Body Mass Index Adversely Affect Thioguanine Nucleotide Levels In Inflammatory Bowel Disease. (9th June 2014) Authors: Subramanian, S; Poon, S; Kneebone, A; Asher, R; Jackson, R; Gregg, B; Collins, P; Probert, C; Dibb, M Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗